Search For "biologics"
LOTTE Biologics to Participate in DCAT Week 2026 in New York to Explore Gl
Updated : 5 days, 9 hours ago IST
Seoul [South Korea], March 9: LOTTE Biologics announced today that it will participate in DCAT Week 2026, a global pharmaceutical and biotechnology industry event taking place in New York from March 23 to 26, to explore new partnership opportunities and strengthen its global presence in the
Read More
SteinCares and Shilpa Biologicals Strike into Licensing Agreement to Expan
Updated : 2 weeks, 3 days ago IST
San Jose [Costa Rica]/ Raichur (Karnataka) [India], February 25: SteinCares, a leading specialty healthcare company in Latin America, and Shilpa Biologicals Pvt. Ltd. (SBPL), a fully integrated biopharmaceutical subsidiary of Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), announce a
Read More
GVRP and Yurogen Biosystems Announce Partnership to Enhance Biologics Drug
Updated : 3 weeks, 1 day ago IST
Hyderabad (Telangana) [India], February 20: GV Research Platform (GVRP) today announced a strategic distribution partnership with Yurogen Biosystems, a global life sciences company specialising in custom biologics development. The collaboration is aimed at expanding access for Indian biotech
Read More
India's pharma sector emerging as global generics powerhouse, need to scal
Updated : 3 months, 1 week ago IST
The report mentioned that India's pharmaceutical industry is entering a decisive new phase marked by tighter supply chains, sustainable manufacturing pressures and an accelerated global shift toward advanced biologics.
Read More
Samsung Biologics to invest USD 4.8 billion in new Songdo bio campus
Updated : 3 months, 1 week ago IST
Samsung Biologics has announced a massive investment of 7 trillion won (about USD 4.8 billion) to build its third bio campus in Songdo, Incheon, marking another step toward expanding its global biopharmaceutical production and advancing next-generation drug manufacturing technologies, as per
Read More
Samsung Biologics secures half of Japan's top 10 pharmas as clients
Updated : 5 months ago IST
Samsung Biologics Co is accelerating its expansion in Japan, the world's third-largest pharmaceutical market. The South Korean company has signed contracts with half of Japan's top 10 pharmaceutical and biotech companies, rapidly strengthening its presence in the region, according to a repor
Read More
Zydus to Enter Global Biologics CDMO Business Plans to Acquire Agenus' U.S
Updated : 9 months, 2 weeks ago IST
New Jersey [US]/ Ahmedabad (Gujarat) [India], June 3: Zydus Lifesciences Ltd. (including its subsidiaries/affiliates, hereafter referred to as "Zydus) today announced its entry into the global biologics contract development and manufacturing organization (CDMO) business through its plan to a
Read More
Experts speculate Samsung's spinoff of foundry business will boost trust a
Updated : 9 months, 2 weeks ago IST
Samsung Electronics is likely to spin off its foundry business from the broader semiconductor division, on the same conflict of interest that separated Samsung Biologics from its biosimilar business and contract drug manufacturing, reports the Korea Herald.
Read More
VJ Biosciences Debuts at 5th Annual Summit of Biologics Conferences with a
Updated : 1 year, 1 month ago IST
Bangalore (Karnataka) [India], February 3: New York-based VJ Group announced the launch of its newest venture, VJ Bio, a biotech company dedicated to creating an integrated ecosystem for innovators to transform their breakthroughs into affordable and effective next-generation therapies. This
Read More
Quantiphi, DDReg Partner to Transform Regulatory Reporting in Life Science
Updated : 1 year, 4 months ago IST
Gurgaon (Haryana) [India], November 6: Quantiphi, a global AI-first digital engineering company and DDReg, a global leader in regulatory expertise today announced a partnership that will address regulatory challenges that pharmaceutical companies, biotechnology firms, medical device and cosm
Read More
EMA approves Biocon Biologics' new monoclonal antibodies facility, renews
Updated : 1 year, 8 months ago IST
According to a press release, this facility, designed to produce multiple drug substances, will now commence the production of biosimilar Bevacizumab, enhancing the company's capacity to meet the growing demand for biologics across European markets.
Read More
Zumutor Biologics Announces Dosing of First Patient with ZM008, a First-in
Updated : 1 year, 9 months ago IST
Boston (Massachusetts) [US]/ Bangalore (Karnataka) [India], June 12: Zumutor Biologics Inc. "Zumutor", a Boston-based clinical stage Oncology Company developing first-in-class monoclonal antibody molecules targeting innate immunological pathways, today announced that the first patient was do
Read More